Pathstone Holdings »

Cara Therapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.2k 12k 0.74

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Cara Therapeutics

Vanguard Group
Chescapmanager
Rosalind Advisors
Federated Investors
AQR Capital Management
Jacobs Levy Equity Management
Bank of America Corporation
Two Sigma Advisers
Millennium Management
Stifel Financial
Two Sigma Investments
Bnp Paribas Arbitrage, Snc
Charles Schwab Investment Management
GSA Capital Partners
Goldman Sachs Group

View all funds holding Cara Therapeutics